# ClinicalTrials.gov record NCT00500110

> PeptideScanner retained ClinicalTrials.gov record NCT00500110 at 2026-07-30T21:42:40.792Z. Its registry update date was 2015-04-28, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00500110-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2015-04-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00500110-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00500110-leuprolide-v1.json
- Content SHA-256: `5a60948b98ae68a6fd1cb4f61e37980974acc55ef60810c406a35f59d20ef4a7`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00500110 ([`ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe`](#source-ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00500110 at 2026-07-30T21:42:40.792Z. Its registry update date was 2015-04-28, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe`](#source-ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00500110 at 2026-07-30T21:42:40.792Z. Its registry update date was 2015-04-28, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe`](#source-ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe`](#source-ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe))

## Sources

<a id="source-ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe"></a>
- **ClinicalTrials.gov record NCT00500110 · retained source version 2015-04-28:9e3de8c6e2feac1fc06d2256d4cc27f48b68281e11ae922cd8798013e315cb4c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00500110) (`ctg-observation-nct00500110-2015-04-28-9e3de8c6e2fe`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00500110." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00500110-leuprolide-v1.json SHA-256: 5a60948b98ae68a6fd1cb4f61e37980974acc55ef60810c406a35f59d20ef4a7.